Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis.
|
17072980 |
2006 |
Pseudotumor Cerebri
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic Survey of Adult-Onset Idiopathic Intracranial Hypertension.
|
29608535 |
2019 |
Autistic Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Individual common variants exert weak effects on the risk for autism spectrum disorders.
|
22843504 |
2012 |
Colorectal Carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
In total, 192 serum samples (92 CRC and 100 matched controls) were tested against a panel of 12 tumor-associated antigens (TAAs): RPH3AL, RPL36, SLP2, p53, survivin, ANAXA4, SEC61B, CCCAP, NYCO16, NMDAR, PLSCR1, and HDAC5.
|
29074220 |
2017 |
Neoplasms
|
0.040 |
GeneticVariation
|
group |
BEFREE |
DNA samples were assessed for loss of heterozygosity (LOH) at the 17p13.3 locus of RPH3AL and the 17p13.1 locus of the tumor suppressor, TP53.
|
26070152 |
2015 |
Neoplasms
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Focal amplifications and homozygous deletions comprising well-known oncogenes (MYC, MDM2, PDGFRA, KIT, MCL1, BCL2L1) and tumor suppressors (TP53, RB1, RPH3AL) were identified.
|
22539591 |
2012 |
Colorectal Carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Circulating RPH3AL autoantibodies are prevalent in patients with CRC, and detection of these autoantibodies might provide a novel non-invasive approach for CRC diagnosis.
|
21536019 |
2011 |
Colorectal Carcinoma
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Since, we observed a higher incidence of a single nucleotide polymorphism (SNP) at the -25 position in the 5'untranslated region (5'UTR-25) of RPH3AL, we performed the genotyping analysis of this SNP in a retrospective CRC cohort (n=134) to assess their clinical importance.
|
17981610 |
2008 |
Colorectal Carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
The RPH3AL gene may play a role as a tumor-suppressor gene in fraction of colorectal cancers, but a minority show RPH3AL gene mutations.
|
12375017 |
2003 |
Neoplasms
|
0.040 |
GeneticVariation
|
group |
BEFREE |
Somatic RPH3AL mutations were identified, providing support for an authentic role as tumor-suppressor gene in colorectal cancer, but only in a minority of cases.
|
12375017 |
2003 |
Neoplasms
|
0.040 |
GeneticVariation
|
group |
BEFREE |
We determined the exon-intron boundaries of RPH3AL and screened the coding region for mutations by direct sequencing in DNA extracted from 33 tumor samples with allelic loss of 17p13, including 10 medulloblastoma, 14 follicular thyroid cancer (FTC), and 9 ovarian cancer specimens.No mutations were identified.
|
10395805 |
1999 |
Carcinogenesis
|
0.020 |
GeneticVariation
|
phenotype |
BEFREE |
Rabphilin-3A-like (RPH3AL) protein functions in the regulation of hormone exocytosis, and mutations in the RPHA3L gene have been associated with tumorigenesis in colorectal cancer (CRC).
|
21536019 |
2011 |
Medulloblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The RPH3AL, which is located at 17p13, has been identified from a candidate 17p13 medulloblastoma tumor suppressor locus.
|
12375017 |
2003 |
Childhood Medulloblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The RPH3AL, which is located at 17p13, has been identified from a candidate 17p13 medulloblastoma tumor suppressor locus.
|
12375017 |
2003 |
Adult Medulloblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The RPH3AL, which is located at 17p13, has been identified from a candidate 17p13 medulloblastoma tumor suppressor locus.
|
12375017 |
2003 |
Medulloblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Thus, despite its location in a homozygously deleted 17p13.3 locus, it is unlikely that RPH3AL is a gene involved in the oncogenesis of medulloblastoma, FTC, or ovarian cancer.
|
10395805 |
1999 |
Childhood Medulloblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Thus, despite its location in a homozygously deleted 17p13.3 locus, it is unlikely that RPH3AL is a gene involved in the oncogenesis of medulloblastoma, FTC, or ovarian cancer.
|
10395805 |
1999 |
Adult Medulloblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Thus, despite its location in a homozygously deleted 17p13.3 locus, it is unlikely that RPH3AL is a gene involved in the oncogenesis of medulloblastoma, FTC, or ovarian cancer.
|
10395805 |
1999 |
Carcinogenesis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Thus, despite its location in a homozygously deleted 17p13.3 locus, it is unlikely that RPH3AL is a gene involved in the oncogenesis of medulloblastoma, FTC, or ovarian cancer.
|
10395805 |
1999 |
Malignant neoplasm of breast
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Thus, genetic alterations in RPH3AL are associated with aggressive behavior of breast cancers and with short survival of patients.
|
26070152 |
2015 |
Malignant neoplasm of colon and/or rectum
|
0.010 |
Biomarker
|
disease |
BEFREE |
Detection of autoantibodies against Rabphilin-3A-like protein as a potential biomarker in patient's sera of colorectal cancer.
|
21536019 |
2011 |
Adenocarcinoma of large intestine
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The recently identified human ortholog of the Rabphillin-3A-Like (RPH3AL) gene, located at the 17p13.3 locus, has been assessed for its mutational status and clinical significance in colorectal adenocarcinoma (CRC).
|
17981610 |
2008 |
Colorectal Neoplasms
|
0.010 |
GeneticVariation
|
group |
LHGDN |
Mutations of rabphillin-3A-like gene in colorectal cancers.
|
12375017 |
2003 |
Follicular thyroid carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We determined the exon-intron boundaries of RPH3AL and screened the coding region for mutations by direct sequencing in DNA extracted from 33 tumor samples with allelic loss of 17p13, including 10 medulloblastoma, 14 follicular thyroid cancer (FTC), and 9 ovarian cancer specimens.No mutations were identified.
|
10395805 |
1999 |
ovarian neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, despite its location in a homozygously deleted 17p13.3 locus, it is unlikely that RPH3AL is a gene involved in the oncogenesis of medulloblastoma, FTC, or ovarian cancer.
|
10395805 |
1999 |